EN
Product
  • Product
  • News

EHRA 2025 | MicroPort EP Showcases Comprehensive Electrophysiology Solutions, Pioneering New Pathways for Arrhythmia Treatment

2025-03-31 16:33:00      Views:

Recently, the European Heart Rhythm Association Annual Meeting 2025 (EHRA 2025) was successfully held in Vienna, Austria. Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort EP") presented its integrated electrophysiology diagnosis and treatment solutions to the international market, centered around four core technologies symbolized as "Ice, Fire, Pulse, and Magnetism".


Key highlights from MicroPort EP's exhibition included:

"Ice": The innovatively designed IceMagic™ surface temperature measurement cryoablation solution;

"Fire": Radiofrequency ablation solution integrating three core technologies - Energy Index (EI), SmartLabel, and AutoPilot™ automatic mapping - based on the Columbus™ 3D EP Navigation System;

"Pulse": Pulsed field ablation system co-developed with Shanghai Shangyang Medical Technology;

"Magnetism": Magbot™ RF ablation catheter and Magbot™ high-density mapping catheter.


Particular attention was drawn to the debut of the disposable cardiac pulsed field ablation catheter featuring dual-loop design. This integrated 3D visualization, high-density mapping and ablation functions, with customizable electrode ablation capabilities, attracting significant attention and inquiries from numerous physicians.


Global EP Experts Gather at EHRA 2025 Witnessing Chinese Innovation

As the sole Chinese company offering complete 3D electrophysiology equipment and consumables solutions, MicroPort EP's booth attracted electrophysiologists from Italy, Germany, France, Austria, Spain, Turkey, Brazil and other countries for product consultations and hands-on experiences.


Brazilian experts Dr. Jorge Francisco Da Silva Filho and Dr. Edvaldo Xavier specifically praised the FireMagic™ TrueForce™ Ablation Catheter. They commended its real-time force feedback and Energy Index (EI)'s reliable ablation parameters, noting these features enable real-time prediction of ablation lesion size and improved procedural efficiency. Both expressed anticipation for future innovations from the company.


Product Focus Sessions Demonstrating Chinese Innovation Depth

During the two-day product sessions, latest advancements in four core technologies were presented with clinical data. In the atrial fibrillation cryoablation session, IceMagic™ cryoablation catheter showcased its surface temperature monitoring technology. Italian expert Dr. Bertaglia recognized this innovation's significance in enhancing procedural safety and efficacy through real-time monitoring of balloon-tissue interface temperature.


The pulsed field ablation solution session highlighted its integration with Columbus™ 3D EP Navigation System's PFA software module, achieving a "3D visualization-modeling-ablation" workflow that improves precision while reducing X-ray dependency.


The robotic magnetic navigation system demonstration featured a remote operation zone where experts could control Shanghai-based Stereotaxis systems in real-time, earning recognition for its software design and remote catheter maneuvering capabilities.


A simulation village was also set up in the exhibition, where experts could use the EasyLoop™ 3D Circular Mapping Catheter and EasyStars™ 3D High-density Mapping Catheter for modeling and auto mapping, and FireMagic™ TrueForce™ Ablation Catheter for ablation. After experiencing the Columbus™ system's AutoPilot™ feature, the five experts from Europe agreed that it can help operators greatly improve the efficacy and accuracy of arrhythmia diagnosis and treatment.


For now, MicroPort EP's products have been exported to more than thirty countries and regions. In the future, MicroPort EP will actively expand its global reach, providing more comprehensive products and professional services to patients and physicians, offering a globally competitive integrated solution for electrophysiology intervention diagnosis and treatment.


Share:
Tel:
(86)(21)60969600
Add:  Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
©Copyright 2024, suncitygroup太阳集团(CHINA)官方网站-欢迎莅临 All rights reserved.
Website License Number:Shanghai ICP Record No.16034362

Internet Drug Information Service Qualification Certificate Number: (Shanghai) - non operational - 2016-0126

  • Home
  • Tel
  • Top